Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients

Neuromuscular Disorders

Volumn 20, Issue 1, 2010, Pages 34-43

  Werlauff, U ^a   Steffensen, B F ^a   Bertelsen, S ^a   Floytrup I ^a   Kristensen, B ^a   Werge, B ^a  

^a Institute for Neuromuscular Diseases   (Denmark)

Author keywords

Assessment methods; Functional abilities; Muscle strength; Spinal muscular atrophy

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTIONAL ASSESSMENT; HUMAN; JOINT MOBILITY; MAJOR CLINICAL STUDY; MALE; MUSCLE CONTRACTURE; MUSCLE STRENGTH; PHYSICAL CAPACITY; PRIORITY JOURNAL; SCOLIOSIS; SPINAL MUSCULAR ATROPHY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ARM; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE STRENGTH; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; YOUNG ADULT;

EID: 74149091358     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2009.11.008     Document Type: Article

References (44)

1. Emery A.E.H. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1 (1991) 19-29
2. Merlini L., Stagni S.B., Marri E., and Granata C. Epidemiology of neuromuscular disorders in the under-20 population in Bologna province, Italy. Neuromuscul Disord 2 (1992) 197-200
3. Arkblad E., Tulinius M., Kroksmark A.K., Henricsson M., and Darin N. A population-based study of genotypic and phenotypic variability in children with spinal muscular atrophy. Acta Paediatr 1 (2009) 1-5
4. Munsat T.L., and Davies K.E. International SMA Consortium meeting report. Neuromuscul Disord 2 (1992) 423-428
5. Feldkötter M., Schwarzer V., Wirth R., et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 70 (2002) 358-362
6. Wirth B., Brichta L., Schrank B., et al. Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum Genet 119 (2006) 422-428
7. Dubowitz V. Chaos in the classification of SMA: a possible resolution. Neuromuscul Disord 5 (1995) 3-5
8. Schwentker E.P., and Gibson D.A. The orthopaedic aspects of spinal muscular atrophy. J Bone Joint Surg Am 58 (1976) 32-38
9. Carter G.T., Abresch R.T., Fowler W.M., et al. Profiles of neuromuscular diseases: spinal muscular atrophy. Am J Phys Med Rehabil 74 (1995) 150-159
10. Evans G.A., Drennan J.C., and Russman B.S. Functional classification and orthopaedic management of spinal muscular atrophy. J Bone Joint Surg Br 63 (1981) 516-522
11. Robinson D., Galasko C.S.B., Delaney C., Williamson J.B., and Barrie J.L. Scoliosis and lung function in spinal muscular atrophy. Eur Spine J 4 (1995) 268-273
12. Kuzuhara S., and Chou S.M. Preservation of the phrenic motoneurons in Werdnig-Hoffmann Disease. Ann Neurol 9 (1981) 506-510
13. Barois A., Estournet B., Duval-Beaupere G., Bataille J., and Leclair-Richard D. Amyotrophie spinale infantile. Rev Neurol 145 (1989) 299-304
14. Samaha F.J., Buncher C.R., Russmann B.S., et al. Pulmonary function in spinal muscular atrophy. J Child Neurol 9 (1994) 326-329
15. Souchon F., Simard L.R., Lebrun S., et al. Clinical and genetic study of chronic (types II and III) childhood onset spinal muscular atrophy. Neuromuscul Disord 6 (1996) 419-424
16. Lyager S., Steffensen B., and Juhl B. Indicators of need for mechanical ventilation in Duchenne muscular dystrophy and spinal muscular atrophy. Chest 108 (1995) 779-785
17. Koch B.M., and Simenson R.L. Upper extremity strength and function in children with SMA II. Arch Phys Med Rehabil 73 (1992) 241-245
18. Benady S.G. Spinal muscular atrophy in childhood: review of 50 cases. Dev Med Child Neurol 20 (1978) 746-757
19. Willig T.N., Paulus J., Lacau Saint Guily J., Béon C., and Navarro J. Swallowing problems in Neuromuscular Disorders. Arch Phys Med Rehabil 75 (1994) 1175-1181
20. Granger M.W., Buschang P.H., Throckmorton G.S., and Iannaccone S.T. Masticatory muscle function in patients with spinal muscular atrophy. Am J Orthod Dentofacial Orthop 115 (1999) 697-702
21. Messina S., Pane M., De Rose P., et al. Feeding difficulties and malnutrition in spinal muscular atrophy type II. Neuromuscul Disord 18 5 (2008) 389-393
22. Innaccone S.T., Russmann B.S., Browne R.H., Buncher R., White M., and Samaha F. Prospective analysis of strength in spinal muscular atrophy. J Child Neurol 15 (2000) 97-101
23. Zerres K., and Rudnik-Schöneborn S. Natural history in proximal spinal muscular atrophy. Clinical analysis of 445 patients and suggestion for a modification of existing classifications. Arch Neurol 52 (1995) 518-523
24. Steffensen B.F., Lyager S., Werge B., Rahbek J., and Mattsson E. Physical capacity in non-ambulatory people with Duchenne muscular dystrophy or spinal muscular atrophy: a longitudinal study. Dev Med Child Neurol 44 9 (2002) 623
25. Kaufmann P., and Iannaccone S.T. Clinical trials in spinal muscular atrophy. Phys Med Rehabil Clin N Am 19 (2008) 653-660
26. Iannaccone S.T., and AmSMART Group. Outcome measures for pediatric spinal muscular atrophy. Arch Neurol 59 (2002) 1445-1450
27. Mercuri E., Mayhew A., Muntoni F., et al. Towards harmonisation of outcome measures for DMD and SMA within TREAT-NMD; Report of three expert workshops. Neuromuscul Disord 18 (2008) 894-903
28. Hyde S.A., Fløytrup I., Glent S., et al. A randomized comparative study of two methods for controlling tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscul Disord 10 (2000) 257-263
29. Steffensen B.F., Hyde S., Attermann J., and Mattsson E. Reliability of the EK scale, a functional test for non-ambulatory persons with Duchenne muscular dystrophy. Adv Physiother 4 (2002) 37-47
30. Brooke M.H., Griggs R.C., Mendell J.R., et al. Clinical trial in Duchenne muscular dystrophy: I. The design of the protocol. Muscle Nerve 4 (1981) 186-187
31. Main M., Kairon H., Mercuri E., and Muntoni F. The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation. Eur J Paediatr Neurol 7 (2003) 155-159
32. Steffensen B.F., Hyde S.A., Lyager S., and Mattsson E. Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy. Physiother Res Int 6 (2001) 119-134
33. Medical Research Council. Aids to the investigation of peripheral nerve injuries. London: Her Majesty's Stationary Office; 1976.
34. Florence J.M., Pandya S., King W., et al. Intrarater reliability of manual muscle test (Medical Research Council scale) grades in Duchenne's muscular dystrophy. Phys Ther 72 (1992) 115-122
35. Scott O.M., Hyde S.A., Goddard C., and Dubowitz V. Quantitation of muscle function in children: a prospective study in Duchenne muscular dystrophy. Muscle Nerve 5 (1982) 291-301
36. American Academy of orthopedic surgeons. Joint motion: method of measuring and recording. Edinburgh and London: E&S Livingstone; 1965.
37. Zawawi K.H., Al-Badawi E.A., Lobo Lobo S., Melis M., and Mehta N.R. An Index for the measurement of normal maximum mouth opening. J Can Dent Assoc 69 (2003) 737-741
38. Rudnik-Schöneborn S., Röhrig D., Morgan G., Wirth B., and Zerres K. Autosomal recessive proximal spinal muscular atrophy in 101 sibs out of 48 families: clinical picture, influence of gender, and genetic implications. Am J Med Genet 51 (1994) 70-76
39. Tiziano F.D., Bertini E., Messina S., et al. The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord 17 (2007) 400-403
40. Escolar D.M., Henricson E.K., Mayhew J., et al. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children. Muscle Nerve 24 (2001) 787-793
41. Merlini L., Mazzone E.S., Solari A., and Morandi L. Reliability of hand-held dynamometry in spinal muscular atrophy. Muscle Nerve 26 (2002) 64-70
42. Miller R.G., Moore D.H., Dronsky V., et al., SMA Study Group. A placebo-controlled trial of gabapentin in spinal muscular atrophy. J Neurol Sci 191 (2001) 127-131
43. Iannaccone S.T., Hynan L.S., and AmSMART group. Reliability of 4 outcome measures in paediatric spinal muscular atrophy. Arch Neurol 60 (2003) 1130-1136
44. Chng S.Y., Wong Y.Q., Hui J.H., et al. Pulmonary function and scoliosis in children with spinal muscular atrophy types II and III. J Paediatr Child Health 39 (2003 Dec) 673-676